Advertisement

Management of Cancer Pain

  • Joseph N. Atallah
Chapter

Abstract

Cancer is the second leading cause of death in the United States after heart diseases. Center of Disease Control estimated number of cancer deaths in 2005 to 559,312. Cancer constitutes 22.8% of the total death in the United States. Lung cancer is the most common fatal cancer in men (31%), followed by colon and rectum (10%), and prostate (9%). In women, lung (26%), breast (15%), and colon and rectum (10%) are the leading causes of cancer death. Most patients with cancer have pain. Cancer pain can develop from tumor invasion, musculoskeletal pain, visceral pain, radiation treatment effect, or neuropathy from chemotherapy. The incidence of pain in cancer patients receiving active treatment for early disease is about 20–25%. The incidence of pain in cancer patient with advanced disease is about 90%. More than 50% of patients with cancer pain have only one or two locations of pain. This fact usually gives the opportunity for interventional pain doctors to help patients with pain. Many cancer patients present with a combination of pain types such as visceral and somatic pain. Up to 90% of cancer pain patients respond well to medical treatment. A high percentage of the remaining individuals also respond well to interventional pain techniques (Portenoy 1989).

Keywords

Cancer Pain Visceral Pain Exit Site Breakthrough Pain Splanchnic Nerve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abram SE, ed. Pain management. In: Miller RD, editor. Atlas of anesthesia. Philadelphia, PA: Churchill Livingstone; 1998. Vol. 6.Google Scholar
  2. Benedetti C, Brock C, Cleeland C, et al. NCCN practice guidelines for cancer pain. Oncology 2000;14:135–50.PubMedGoogle Scholar
  3. Bennett G, Burchiel K, Buchser E, et al. Clinical guidelines for intraspinal infusion: report of an expert panel. J Pain Symptom Manage. 2000;20:S37–S43.PubMedCrossRefGoogle Scholar
  4. Berland D. Pain management in patients with advanced cancer. Ann Intern Med. 2000;132:593.PubMedGoogle Scholar
  5. Burton AW, Driver LC, Mendoza TR, et al. Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises. Clin J Pain. 2004a;20:195–97.PubMedCrossRefGoogle Scholar
  6. Burton AW, Rajagopal A, Hassenbusch SJ, et al. Reduction in pain and oral opioid intake after intrathecal pump implantation. In: Program and abstracts of the International Association for the Study of Pain 10th World Congress on Pain, August 17–22, 2002, San Diego, CA.Google Scholar
  7. Burton AW, Rajagopal A, Shah HN, et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004b;5:239–47.PubMedCrossRefGoogle Scholar
  8. Carr DB, Goudas LC, Balk EM, et al. Evidence report on the treatment of pain in cancer patients. J Nat Cancer Inst Monogri. 2004;32:23–31.CrossRefGoogle Scholar
  9. Cherny NI. The management of cancer pain. CA Cancer J Clin. 2000;50:70–116. AbstractPubMedCrossRefGoogle Scholar
  10. Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med. 1993;86:264–266.PubMedGoogle Scholar
  11. de Leon-Casasola OA. Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control 2000;7:142–8.PubMedGoogle Scholar
  12. Doggrell SA. Intrathecal ziconotide for refractory pain. Expert Opin Invest Drugs. 2004;13:875–77.CrossRefGoogle Scholar
  13. Eisenach JC, Du Pen S, Dubois M, et al. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 1995;61:391–99.PubMedCrossRefGoogle Scholar
  14. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290–5.PubMedCrossRefGoogle Scholar
  15. Erdine S, Talu GK. Cost effectiveness of implantable devices versus tunneled catheters. Curr Rev Pain. 1998;2:157–62.Google Scholar
  16. Fukshansky M, Are M, Burton AW. The role of opioids in cancer pain management. Pain Pract. 2005;5:43–54.PubMedCrossRefGoogle Scholar
  17. Gilmer-Hill HS, Boggan JE, Smith KA, et al. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. Surg Neurol. 1999;51:12–5.PubMedCrossRefGoogle Scholar
  18. Jacox AK, Carr DB, Payne R, et al. Management of cancer pain: clinical practice guideline No. 9. Rockville, MD: Agency for Healthcare Policy and Research, US Department of Health and Human Services, Public Health Service; 1994: AHCPR Publication No. 94-0592.Google Scholar
  19. Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control 2000;7:149–56.PubMedGoogle Scholar
  20. Patt RB. Cancer pain. Philadelphia, PA: Lippincott; 1993.Google Scholar
  21. Plancarte R, de Leon-Casasola OA, El-Helay M, et al. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth. 1997;22:562–8.PubMedGoogle Scholar
  22. Portenoy RK. Cancer pain: epidemiology and syndromes. Cancer 1989;63(11 suppl): 2298–307.PubMedCrossRefGoogle Scholar
  23. Shah HN, Burton AW, Mendoza T, et al. Neurolytic blockade of the splanchnic nerves block relieves refractory pain associated with upper abdominal malignancy. In: Program and Abstracts of the Annual Meeting of the American Society of Anesthesiologists; October 11–15, 2003, San Francisco, CA; Abstract A1024.Google Scholar
  24. Stoelting RK, Miller RD. Spinal and epidural anesthesia. In: Stoelting RK, Miller RD, editors. Basics of anesthesia. Philadelphia, PA: Churchill Livingstone; 2000. pp. 168–95.Google Scholar
  25. Waldman SD. Interventional pain management. Phildelphia, PA: Saunders; 2001.Google Scholar
  26. Wong GY, Brown DL. Celiac plexus block for cancer pain. In: Utney W, editor. Techniques in regional anesthesia and pain management. Vol. 1. Philadelphia, PA: W.B. Saunders; 1997.Google Scholar
  27. World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. WHO Tech Rep Ser. 1990;804:1–73.Google Scholar
  28. Zech DFJ, Grond S, Lynch J, et al. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65–76.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Joseph N. Atallah
    • 1
  1. 1.Department of AnesthesiologyUniversity of Toledo Medical CenterToledoUSA

Personalised recommendations